Compare · EGLX vs MCK
EGLX vs MCK
Side-by-side comparison of Enthusiast Gaming Holdings Inc. (EGLX) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- EGLX operates in Miscellaneous, while MCK operates in Health Care - the two are in different parts of the market.
- MCK is the larger of the two at $92.15B, about 339.8x EGLX ($271.2M).
- MCK has hit the wire 35 times in the past 4 weeks while EGLX has been quiet.
- MCK has more recent analyst coverage (25 ratings vs 5 for EGLX).
- Company
- Enthusiast Gaming Holdings Inc.
- McKesson Corporation
- Price
- $0.27-1.54%
- $780.40+1.80%
- Market cap
- $271.2M
- $92.15B
- 1M return
- -
- +5.97%
- 1Y return
- -
- +10.28%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 35
- Recent ratings
- 5
- 25
Enthusiast Gaming Holdings Inc.
Enthusiast Gaming Holdings Inc. engages in the media, content, entertainment, and esports businesses the United States, Canada, and internationally. The company operates an online network of approximately 100 gaming related websites; owns and operates Enthusiast Gaming Live Expo, a video-gaming expo; provides management and support services to players involved in professional gaming; and owns and manages esports teams, which cover games comprising Call of Duty, Madden, Fortnite, Overwatch, Apex, and Valorant; and produces and programs approximately 30 weekly shows across AVOD and OTT channels, and represents approximately 500 gaming influencers across YouTube and Twitch. It also operates Luminosity Gaming, an eSports franchise; and hosts other gaming events. The company is headquartered in Toronto, Canada.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest EGLX
- SEC Form 15F-12B filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form S-8 POS filed by Enthusiast Gaming Holdings Inc.
- SEC Form F-10/A filed by Enthusiast Gaming Holdings Inc. (Amendment)
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
Latest MCK
- SVP, Controller & CAO Rutledge Napoleon B Jr sold $101,612 worth of shares (133 units at $764.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 632 units (SEC Form 4)
- EVP, Chief Strategy & BDO Rodgers Thomas L sold $604,420 worth of shares (822 units at $735.30) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 2,268 units (SEC Form 4)
- EVP & Chief HR Officer Smith Leann B sold $1,331,255 worth of shares (1,810 units at $735.50) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 4,798 units (SEC Form 4)
- McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions
- SEC Form 4 filed by EVP & CFO Cheung Kenny K
- SEC Form 3 filed by new insider Cheung Kenny K
- SEC Form SD filed by McKesson Corporation
- EVP and Chief Legal Officer Lau Michele sold $2,701,870 worth of shares (3,550 units at $761.09) as part of a pre-agreed trading plan, decreasing direct ownership by 52% to 3,247 units (SEC Form 4)
- EVP & CFO Vitalone Britt J. converted options into 1,476 shares and covered exercise/tax liability with 581 shares, increasing direct ownership by 4% to 21,953 units (SEC Form 4)
- Chief Executive Officer Tyler Brian S. converted options into 4,579 shares and covered exercise/tax liability with 1,831 shares, increasing direct ownership by 11% to 27,774 units (SEC Form 4)